KR-31831, a new synthetic anti-ischemic agent, inhibits in vivo and in vitro angiogenesis. [electronic resource]
Producer: 20070209Description: 502-8 p. digitalISSN:- 1226-3613
- Angiogenesis Inhibitors -- pharmacology
- Animals
- Benzopyrans -- pharmacology
- Cattle
- Cell Movement -- drug effects
- Cells, Cultured
- Endothelial Cells -- drug effects
- Fibroblast Growth Factor 2 -- metabolism
- Imidazoles -- pharmacology
- In Vitro Techniques
- Ischemia -- drug therapy
- Male
- Matrix Metalloproteinase 2 -- metabolism
- Mice
- Mice, Inbred C57BL
- Models, Biological
- Neovascularization, Pathologic -- drug therapy
- Neovascularization, Physiologic -- drug effects
- Receptor, Fibroblast Growth Factor, Type 2 -- metabolism
- Vascular Endothelial Growth Factor Receptor-2 -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.